In its classic hormonal role, erythropoietin (EPO) is produced by the kidney and regulates
the number of erythrocytes within the circulation to provide adequate tissue oxygenation …

Background Chronic diseases reduce the availability of iron for effective erythropoiesis. This
review summarises clinical consequences of iron deficiency (ID) and anaemia in cancer …

Background and Objectives Although several studies demonstrated that platelet count is
higher in women, decreases with age, and is influenced by genetic background, most …

Background Only limited data on the prevalence of iron deficiency (ID) and its correlation
with clinical parameters are available in cancer. ID frequently contributes to the …

Erythropoietin (EPO) is a tissue-protective cytokine preventing vascular spasm, apoptosis,
and inflammatory responses. Although best known for its role in hematopoietic lineages …

Background: Sampling a healthy reference population to generate reference intervals (RIs)
for complete blood count (CBC) parameters is not common for pediatric and geriatric ages …

Iron deficiency and iron deficiency-associated anemia are common complications in cancer
patients. Most iron deficient cancer patients present with functional iron deficiency (FID), a …

Background Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) are
assumed to be prognostic factors in many diseases such as inflammatory diseases …

Anemia, usually due to iron deficiency, is highly prevalent among patients with colorectal
cancer. Inflammatory cytokines lead to iron restricted erythropoiesis further decreasing iron …

Thrombocytopenia is a common finding in malaria, but its prognostic value has not been
addressed in children. The relationship between thrombocytopenia (platelet count< …